Raymond James Financial Inc. Takes $34.72 Million Position in Henry Schein, Inc. (NASDAQ:HSIC)

Raymond James Financial Inc. purchased a new stake in Henry Schein, Inc. (NASDAQ:HSIC) during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 501,734 shares of the company’s stock, valued at approximately $34,720,000. Raymond James Financial Inc. owned about 0.40% of Henry Schein as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. Versant Capital Management Inc grew its position in Henry Schein by 274.6% during the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock worth $32,000 after buying an additional 335 shares in the last quarter. Venturi Wealth Management LLC grew its stake in shares of Henry Schein by 3,347.1% in the 4th quarter. Venturi Wealth Management LLC now owns 586 shares of the company’s stock valued at $41,000 after purchasing an additional 569 shares during the period. Quent Capital LLC grew its stake in shares of Henry Schein by 91.2% in the 4th quarter. Quent Capital LLC now owns 677 shares of the company’s stock valued at $47,000 after purchasing an additional 323 shares during the period. Smartleaf Asset Management LLC grew its stake in shares of Henry Schein by 23.2% in the 4th quarter. Smartleaf Asset Management LLC now owns 759 shares of the company’s stock valued at $52,000 after purchasing an additional 143 shares during the period. Finally, City State Bank bought a new stake in shares of Henry Schein in the 4th quarter valued at approximately $55,000. 96.62% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on HSIC shares. Barrington Research reiterated an “outperform” rating and issued a $90.00 price objective on shares of Henry Schein in a research note on Wednesday, February 26th. UBS Group reduced their target price on Henry Schein from $83.00 to $80.00 and set a “neutral” rating on the stock in a report on Wednesday, February 26th. Bank of America raised Henry Schein from an “underperform” rating to a “buy” rating and boosted their target price for the stock from $69.00 to $84.00 in a report on Monday, January 6th. Mizuho initiated coverage on Henry Schein in a report on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 target price on the stock. Finally, Wells Fargo & Company initiated coverage on Henry Schein in a report on Friday, February 14th. They issued an “equal weight” rating and a $80.00 target price on the stock. Six research analysts have rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $81.10.

Henry Schein Price Performance

HSIC stock opened at $69.81 on Friday. The stock has a 50-day moving average price of $74.78 and a two-hundred day moving average price of $72.62. Henry Schein, Inc. has a 1 year low of $63.67 and a 1 year high of $82.49. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. The stock has a market cap of $8.67 billion, a PE ratio of 28.73, a price-to-earnings-growth ratio of 2.13 and a beta of 0.90.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings data on Tuesday, February 25th. The company reported $1.19 EPS for the quarter, missing analysts’ consensus estimates of $1.23 by ($0.04). Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The business had revenue of $3.19 billion for the quarter, compared to analyst estimates of $3.25 billion. During the same quarter in the prior year, the company earned $0.66 earnings per share. The company’s quarterly revenue was up 5.8% on a year-over-year basis. Equities analysts forecast that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.